HUMA: Humacyte, Inc. Stock

by  •  • Comments Off on HUMA: Humacyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 530.11
Enterprise Value ($M) 571.66
Book Value ($M) -63.72
Book Value / Share -0.50
Price / Book -8.32
NCAV ($M) -155.48
NCAV / Share -1.21
Price / NCAV -3.41

Profitability (mra)
Return on Invested Capital (ROIC) -9.76
Return on Assets (ROA) -1.19
Return on Equity (ROE) -11.29

Liquidity (mrq)
Quick Ratio 1.10
Current Ratio 1.10

Balance Sheet (mrq) ($M)
Current Assets 23.00
Assets 114.76
Liabilities 178.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-20 13D/A Niklason Laura E 4.60 -22.03
11-08 13G BlackRock, Inc. 6.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 1,290,162 3,279,394 39.34
2025-01-14 844,476 2,563,922 32.94
2025-01-13 919,508 2,690,345 34.18
2025-01-10 768,415 2,533,925 30.33

(click for more detail)

Similar Companies
HALO – Halozyme Therapeutics, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc.


Financial data and stock pages provided by
Fintel.io